| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 55.6% | 10/18 |
| Female | 44.4% | 8/18 |
| Indifferent | 0% | 0/18 |
| Unknown | 0% | 0/18 |
| General | ||
| 11.1% | 2/18 | |
| 22.2% | 4/18 | |
| 5.6% | 1/18 | |
| 44.4% | 8/18 | |
| 33.3% | 6/18 | |
| 100% | 18/18 | |
| 83.3% | 15/18 | |
| 72.2% | 13/18 | |
| 77.8% | 14/18 | |
| 66.7% | 8/12 | |
| Neurology | ||
| 27.8% | 5/18 | |
| 44.4% | 8/18 | |
| 27.8% | 5/18 | |
| Facial abnormalities | ||
| 33.3% | 6/18 | |
| 88.9% | 16/18 | |
| 83.3% | 15/18 | |
| 72.2% | 13/18 | |
| Visual and hearing impairments | ||
| 11.1% | 2/18 | |
| 66.7% | 12/18 | |
| Heart | ||
| 27.8% | 5/18 | |
| Pulmonary | ||
| Abnormality of the lungs | 0% | 0/18 |
| Gastrointestinal | ||
| 22.2% | 4/18 | |
| Urogenital | ||
| 27.8% | 5/18 | |
| Skeleton | ||
| 94.4% | 17/18 | |
| Skin / Hair / Nails | ||
| 44.4% | 8/18 | |
| Endocrine / Immunological / Metabolic | ||
| 5.6% | 1/18 | |
| 5.6% | 1/18 | |
| 11.1% | 2/18 | |
| Neoplasia | ||
| 16.7% | 3/18 | |
EP300